Truist Financial Corp Moderna, Inc. Transaction History

Truist Financial Corp

$65 Billion
Q2 2024

A detailed history of Truist Financial Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 18,657 shares of MRNA stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,657

Previous 17,382 7.34%

Holding current value

$1.23 Million

Previous $1.85 Million 19.6%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	BUY	$101.21 - $166.61 $129,042 - $212,427	1,275 Added 7.34%	18,657 $2.22 Million
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $199,082 - $269,206	-2,332 Reduced 11.83%	17,382 $1.85 Million
Q4 2023 Feb 02, 2024	SELL	$69.51 - $104.43 $10,843 - $16,291	-156 Reduced 0.79%	19,714 $1.96 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.13 Million - $1.48 Million	11,718 Added 143.74%	19,870 $2.05 Million
Q2 2023 Aug 01, 2023	BUY	$118.5 - $160.53 $109,731 - $148,650	926 Added 12.81%	8,152 $990,000
Q1 2023 May 05, 2023	SELL	$135.66 - $197.02 $215,835 - $313,458	-1,591 Reduced 18.04%	7,226 $1.11 Million
Q4 2022 Feb 17, 2023	BUY	$118.38 - $210.04 $263,395 - $467,339	2,225 Added 33.75%	8,817 $1.58 Million
Q3 2022 Oct 26, 2022	BUY	$118.07 - $194.18 $36,129 - $59,419	306 Added 4.87%	6,592 $779,000
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $93,938 - $141,625	-802 Reduced 11.31%	6,286 $899,000
Q1 2022 Apr 22, 2022	SELL	$126.46 - $235.05 $4.21 Million - $7.82 Million	-33,285 Reduced 82.44%	7,088 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $842,534 - $1.37 Million	-3,731 Reduced 8.46%	40,373 $10.3 Million
Q3 2021 Nov 05, 2021	SELL	$221.9 - $484.47 $2.38 Million - $5.2 Million	-10,738 Reduced 19.58%	44,104 $17 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.06 Million - $1.91 Million	-8,131 Reduced 12.91%	54,842 $12.9 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $1.52 Million - $2.59 Million	13,934 Added 28.41%	62,973 $8.25 Million
Q4 2020 Nov 19, 2021	SELL	$65.74 - $169.86 $679,948 - $1.76 Million	-10,343 Reduced 17.42%	49,039 $5.12 Million
Q4 2020 Feb 18, 2021	BUY	$65.74 - $169.86 $1.86 Million - $4.8 Million	28,270 Added 90.87%	59,382 $6.2 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $1.43 Million - $2.5 Million	26,330 Added 550.61%	31,112 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $141,881 - $382,560	4,782 New	4,782 $307,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Moderna, Inc. Transaction History